Squire Investment Management Company LLC Sells 5,440 Shares of Colgate-Palmolive (NYSE:CL)

Squire Investment Management Company LLC lessened its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 67.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,670 shares of the company's stock after selling 5,440 shares during the quarter. Squire Investment Management Company LLC's holdings in Colgate-Palmolive were worth $277,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of CL. M&G Plc bought a new position in Colgate-Palmolive in the first quarter valued at about $3,812,000. Gordian Advisors LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $602,000. Vontobel Holding Ltd. grew its position in shares of Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company's stock worth $82,626,000 after buying an additional 550,750 shares during the period. PGGM Investments raised its stake in shares of Colgate-Palmolive by 171.8% during the second quarter. PGGM Investments now owns 157,608 shares of the company's stock worth $15,294,000 after buying an additional 99,624 shares during the last quarter. Finally, QRG Capital Management Inc. lifted its holdings in Colgate-Palmolive by 11.2% in the second quarter. QRG Capital Management Inc. now owns 57,275 shares of the company's stock valued at $5,558,000 after buying an additional 5,751 shares during the period. 80.41% of the stock is owned by institutional investors.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Up 2.3 %

CL traded up $2.11 on Friday, hitting $93.56. 7,328,993 shares of the company were exchanged, compared to its average volume of 4,387,812. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock's fifty day moving average is $99.31 and its 200-day moving average is $98.45. The company has a market cap of $76.44 billion, a PE ratio of 26.81, a PEG ratio of 3.25 and a beta of 0.42. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive's payout ratio is presently 57.31%.

Wall Street Analyst Weigh In

Several brokerages have commented on CL. Jefferies Financial Group cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their target price for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Barclays increased their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a research note on Monday, July 29th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. Sanford C. Bernstein increased their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research report on Tuesday, July 30th. Finally, Hsbc Global Res cut shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.